or Try an Advanced Search...

    Technical Analysis for ICCM - IceCure Medical Ltd.

    Grade Last Price % Change Price Change
    F 0.60 -1.20% -0.01
    ICCM closed down 1.2 percent on Wednesday, November 20, 2024, on approximately normal volume. The stock exhibited some range contraction during this trading session as price made an NR7 -- narrowest range of the last seven sessions.
    Earnings due: Nov 26
    *** please verify all earnings dates ***
    1 Watcher
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Weak or Absent Down Down Down
    Historical ICCM trend table...
    Date Alert Name Type % Chg
    NR7 Range Contraction 0.00%
    Narrow Range Bar Range Contraction 0.00%
    Wide Bands Range Expansion 0.00%
    Oversold Stochastic Weakness 0.00%
    Narrow Range Bar Range Contraction -1.20%
    Wide Bands Range Expansion -1.20%
    Gapped Up Strength -1.20%
    Oversold Stochastic Weakness -1.20%
    Wide Bands Range Expansion 0.42%
    Gapped Up Strength 0.42%
    Older End-of-Day Signals for ICCM ...

       Recent Intraday Alerts

    Alert Time
    10 DMA Resistance about 18 hours ago
    Down 2 % about 18 hours ago
    Down 1% about 18 hours ago
    Up 1% about 18 hours ago
    Possible NR7 about 18 hours ago
    View Earlier Intraday Alerts

    Get a Trading Sidekick!

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Track My Stocks
    Configure default chart indicators
    ICCM Chart by TradingView
    Basic chart:

    Profile

    Founded in 2006, Israel-based IceCure Medical develops and markets an advanced liquid-nitrogen-based cryoablation therapy for the treatment of tumors (benign and cancerous) by freezing, with the primary focus areas being breast, kidney, bone and lung cancer. Its minimally-invasive technology is a safe and effective alternative to hospital surgical tumor removal that is easily performed in a relatively short procedure. The system is marketed and sold worldwide, after receiving FDA and CE approvals.
    Classification
    Sector: Healthcare
    Industry: Medical Care Facilities
    Keywords: Medicine Clinical Medicine Tumor Breast Cancer FDA Interventional Radiology Lung Cancer Cryoablation Interventional Oncology

    Is ICCM a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 0 bullish, 3 bearish and 2 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    Nov 20 IceCure Medical to Report Third Quarter 2024 Financial & Operational Results on November 26, 2024
    Nov 19 IceCure's ProSense® Chosen for Breast Cryoablation Study Led by the Prestigious European Institute of Oncology with Sponsorship from the Italian Ministry of Health
    Nov 11 IceCure’s cryoablation system for breast cancer treatment gains FDA panel support
    Nov 8 IceCure gets favorable FDA AdCom vote for ProSense System
    Nov 8 FDA Advisory Panel Votes in Favor of IceCure's ProSense® Cryoablation Benefit-Risk Profile in Early-Stage Low Risk Breast Cancer
    Oct 29 Upcoming FDA Advisory Panel for IceCure's ProSense® Marketing Authorization Receives Large Number of Public Comments from Stakeholders
    Oct 21 IceCure Receives Notice of Allowance from U.S. Patent and Trademark Office for its Next-Generation Cryoablation System
    Oct 15 IceCure Medical files to sell ordinary shares and warrants
    Oct 10 Alignment HealthCare Partners With Intermountain Health in Nevada
    Oct 7 IceCure's ProSense® Featured in 6 Global Studies on Cryoablation of Breast Tumors at the 2024 European Society of Breast Imaging Conference
    See more ICCM news...

    Comments

    S

    SociableGnat503 about 1 year ago

    Is anyone here following this one? 

    0 Reply
    View full discussion...

    Indicators

    Indicator Value
    52 Week High 1.57
    52 Week Low 0.48
    Average Volume 705,073
    200-Day Moving Average 0.90
    50-Day Moving Average 0.63
    20-Day Moving Average 0.68
    10-Day Moving Average 0.62
    Average True Range 0.07
    RSI (14) 44.44
    ADX 20.91
    +DI 19.25
    -DI 25.40
    Chandelier Exit (Long, 3 ATRs) 0.70
    Chandelier Exit (Short, 3 ATRs) 0.73
    Upper Bollinger Bands 0.89
    Lower Bollinger Band 0.48
    Percent B (%b) 0.3
    BandWidth 61.26
    MACD Line -0.01
    MACD Signal Line 0.00
    MACD Histogram -0.016
    Fundamentals Value
    Market Cap 27.55 Million
    Num Shares 45.7 Million
    EPS -0.36
    Price-to-Earnings (P/E) Ratio -1.67
    Price-to-Sales 22.29
    Price-to-Book 4.42
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 0.64
    Resistance 3 (R3) 0.65 0.63 0.64
    Resistance 2 (R2) 0.63 0.62 0.63 0.63
    Resistance 1 (R1) 0.62 0.62 0.63 0.62 0.63
    Pivot Point 0.61 0.61 0.61 0.60 0.61
    Support 1 (S1) 0.59 0.59 0.60 0.59 0.57
    Support 2 (S2) 0.58 0.59 0.58 0.57
    Support 3 (S3) 0.56 0.58 0.57
    Support 4 (S4) 0.56